Ishares Genomics Immunology Etf Price on November 7, 2024
| IDNA Etf | USD 23.58 0.42 1.75% |
Below is the normalized historical share price chart for iShares Genomics Immunology extending back to June 13, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of IShares Genomics stands at 23.58, as last reported on the 13th of December 2024, with the highest price reaching 23.93 and the lowest price hitting 23.56 during the day.
If you're considering investing in IShares Etf, it is important to understand the factors that can impact its price. iShares Genomics Imm holds Efficiency (Sharpe) Ratio of -0.068, which attests that the entity had a -0.068% return per unit of risk over the last 3 months. iShares Genomics Imm exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Genomics' Risk Adjusted Performance of (0.02), market risk adjusted performance of (0.05), and Standard Deviation of 1.21 to validate the risk estimate we provide.
IShares Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
3 y Volatility 25.27 | 200 Day MA 24.024 | 1 y Volatility 19.32 | 50 Day MA 24.2894 | Inception Date 2019-06-11 |
IShares |
Sharpe Ratio = -0.068
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IDNA |
Estimated Market Risk
| 1.19 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average IShares Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Genomics by adding IShares Genomics to a well-diversified portfolio.
Average Mkt Cap Mil 12.2 K |
Related Headline
Invesco DWA Headline on 7th of November 2024
Top ASX Dividend Stocks To Consider In November 2024 by finance.yahoo.com
As the ASX200 experiences a slight dip of 0.25 percent at 8178 points amidst global market shifts following Donald Trumps re-election, Australian investors are closely monitoring dividend stocks for stable returns in a volatile environment. In such times, selecting stocks with strong dividend yields can provide a reliable income stream, making them an attractive option for those looking to navigate the current economic landscape.
IShares Genomics Valuation on November 7, 2024
It is possible to determine the worth of IShares Genomics on a given historical date. On November 7, 2024 IShares was worth 25.27 at the beginning of the trading date compared to the closed value of 25.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of IShares Genomics etf. Still, in general, we apply an absolute valuation method to find IShares Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of IShares Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against IShares Genomics' related companies.
| Open | High | Low | Close | Volume | |
| 25.00 | 25.14 | 24.86 | 25.07 | 24,712 | |
11/07/2024 | 25.27 | 25.48 | 25.24 | 25.37 | 36,339 |
| 25.25 | 25.40 | 25.25 | 25.38 | 21,424 |
| Backtest IShares Genomics | | | IShares Genomics History | | | IShares Genomics Valuation | Previous | Next |
IShares Genomics Trading Date Momentum on November 7, 2024
| On November 08 2024 iShares Genomics Immunology was traded for 25.38 at the closing time. The top price for the day was 25.40 and the lowest listed price was 25.25 . The trading volume for the day was 21.4 K. The trading history from November 8, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.04% . The trading date delta against the current closing price is 9.14% . |
iShares Genomics Imm Fundamentals Correlations and Trends
By evaluating IShares Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among IShares Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. IShares financial account trend analysis is a perfect complement when working with valuation or volatility modules.About IShares Genomics Etf history
IShares Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IShares is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in iShares Genomics Imm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IShares Genomics stock prices may prove useful in developing a viable investing in IShares Genomics
The fund generally will invest at least 80 percent of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Genomics Immunology is traded on NYSEARCA Exchange in the United States.
IShares Genomics Etf Technical Analysis
IShares Genomics technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
IShares Genomics Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
iShares Genomics Immunology cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE ARCA Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
IShares Genomics December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how IShares Genomics etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Genomics shares will generate the highest return on investment. By undertsting and applying IShares Genomics etf market strength indicators, traders can identify iShares Genomics Immunology entry and exit signals to maximize returns
IShares Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for IShares Genomics' price direction in advance. Along with the technical and fundamental analysis of IShares Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of IShares to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.